Best Biotech Trades Of 2020: New Picks Coming For 2021

Stock, Trading, Monitor, Business

Image source: Pixabay

We were on vacation over the past week, and that combined with all the news from the Capitol and the worsening pandemic makes it a challenging week to look back on. Nonetheless, stocks are booming and many financial writers and analysts feel there is room for optimism.

We are in the midst of a sector rotation, so I’ve been spending more time and money on areas outside of healthcare while keeping my core biotech stocks intact. Lets me start by giving a brief summary of the market and our model healthcare portfolio. Amidst the turmoil of the past week we have a market that finds a way to renew itself with the most optimistic scenarios.

The DOW was up 1.61%, the S&P was up 1.83%, and the NASDAQ was up 2.43%. Energy stocks were up over 9% this past week and financials rose 2.4%, thus demonstrating the trend toward portfolio rotation or “re-opening’ trade. Bank earnings are slated for next week.

Most ETFs in Healthcare and Biotechs are At or Near One-Year Highs

PORTFOLIO                      
Stock/ETF Ticker Price Weight P 11/13 P 11/27 %Perf Price QTR 2020 Yr Price  
    10/25       1 mo. 12/31 % % Perf 1/10/21  
iShares NAZ Bio IBB 136 25 141.06 143.22 2.27 151.5 11.9 25.7 158.23  
iShares Russell 2k IWM 163 10 173.51 184.37 16.56 196.4 30.9 18.3 207.72  
Merck MRK 80 10 81.09 79.86 2.4 81.77 -1.39 -10 83.03  
United Health UNH 330 25 355.67 337.94 5.44 350.7 12.5 19.3 363.39  
SPDR S&P Bio XBI 117 5 125.04 131.46 11.95 140.8 26.3 48 149.54  
Healthcare SPDR XLV 108 25 112.12 109.44 3.35 113.4 7.55 11.4 117.39  
1 2
View single page >> |

Disclosure: None.

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.